BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 15715101)

  • 1. [Criteria for suppressive dosage of thyroxine administered in thyroid cancer].
    Khmara IM; Demidchik IuE; Shapet'ko MN
    Vopr Onkol; 2004; 50(5):580-4. PubMed ID: 15715101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pregnancy following operative and complementary treatment of thyroid cancer.
    Pomorski L; Bartos M; Narebski J
    Zentralbl Gynakol; 2000; 122(7):383-6. PubMed ID: 10951709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic outcomes of papillary thyroid carcinomas with tumors more advanced than T1N0M0.
    Lin JD; Lin KJ; Chao TC; Hseuh C; Tsang NM
    Radiother Oncol; 2008 Oct; 89(1):97-104. PubMed ID: 18534700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Levothyroxine replacement therapy after thyroid surgery.
    Verhaert N; Vander Poorten V; Delaere P; Bex M; Debruyne F
    B-ENT; 2006; 2(3):129-33. PubMed ID: 17067083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjuvant external-beam radiotherapy in patients with high-risk well-differentiated thyroid cancer.
    Chen PV; Osborne R; Ahn E; Avitia S; Juillard G
    Ear Nose Throat J; 2009 Jul; 88(7):E01. PubMed ID: 19623515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic factors in well-differentiated thyroid carcinoma in patients treated and followed in the same institution.
    Cappelli C; Pirola I; Braga M; De Martino E; Morassi ML; Gandossi E; Mattanza C; Balzano R; Castellano M; Rosei EA
    Ann Ital Chir; 2006; 77(2):107-13. PubMed ID: 17147082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors for the development of hypothyroidism after hemithyroidectomy.
    Miller FR; Paulson D; Prihoda TJ; Otto RA
    Arch Otolaryngol Head Neck Surg; 2006 Jan; 132(1):36-8. PubMed ID: 16415427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The effect of laryngectomy and postoperative radiotheraphy on thyroid gland functions].
    Cinar U; Yiğit O; Alkan S; Uslu B; Topuz E; Unsal O; Akgül G; Dadaş B
    Kulak Burun Bogaz Ihtis Derg; 2003 Jun; 10(6):226-30. PubMed ID: 13679689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predicting thyroxine requirements following total thyroidectomy.
    Mistry D; Atkin S; Atkinson H; Gunasekaran S; Sylvester D; Rigby AS; England RJ
    Clin Endocrinol (Oxf); 2011 Mar; 74(3):384-7. PubMed ID: 21198738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thyroid function after unilateral total lobectomy: risk factors for postoperative hypothyroidism.
    De Carlucci D; Tavares MR; Obara MT; Martins LA; Hojaij FC; Cernea CR
    Arch Otolaryngol Head Neck Surg; 2008 Oct; 134(10):1076-9. PubMed ID: 18936354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Bone tissue mineral density in patients with thyroid gland cancer on levothyroxine natrium therapy].
    Khmara IM; Tolkachev IuV
    Klin Med (Mosk); 2005; 83(10):61-5. PubMed ID: 16320850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid rise in serum thyrotropin concentrations after thyroidectomy or withdrawal of suppressive thyroxine therapy in preparation for radioactive iodine administration to patients with differentiated thyroid cancer.
    Serhal DI; Nasrallah MP; Arafah BM
    J Clin Endocrinol Metab; 2004 Jul; 89(7):3285-9. PubMed ID: 15240604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment for microcarcinoma of the thyroid--clinical experience.
    Küçük NO; Tari P; Tokmak E; Aras G
    Clin Nucl Med; 2007 Apr; 32(4):279-81. PubMed ID: 17413573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors associated with postoperative hypothyroidism after lobectomy in papillary thyroid microcarcinoma patients.
    Park HK; Kim DW; Ha TK; Choo HJ; Park YM; Jung SJ; Kim DH; Bae SK
    Endocr Res; 2015; 40(1):49-53. PubMed ID: 25111668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The comparative study of bone mineral density between premenopausal women receiving long term suppressive doses of levothyroxine for well-differentiated thyroid cancer with healthy premenopausal women.
    Sajjinanont T; Rajchadara S; Sriassawaamorn N; Panichkul S
    J Med Assoc Thai; 2005 Nov; 88 Suppl 3():S71-6. PubMed ID: 16858944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hormonal replacement therapy in women after surgery for thyroid cancer treated with suppressive doses of L-thyroxine].
    Jastrzebska H; Gietka-Czernel M; Zgliczyński S
    Wiad Lek; 2001; 54 Suppl 1():383-8. PubMed ID: 12182054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Age influences TSH serum levels after withdrawal of l-thyroxine or rhTSH stimulation in patients affected by differentiated thyroid cancer.
    Montesano T; Durante C; Attard M; Crocetti U; Meringolo D; Bruno R; Tumino S; Rubello D; Al-Nahhas A; Colandrea M; Maranghi M; Travascio L; Ronga G; Torlontano M
    Biomed Pharmacother; 2007 Sep; 61(8):468-71. PubMed ID: 17553654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Post-thyroidectomy osteoporosis].
    Wang Y; Wu H; Zhou J
    Zhonghua Zhong Liu Za Zhi; 1996 Jul; 18(4):308-9. PubMed ID: 9387330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Follow-up of differentiated thyroid carcinoma.
    Pagano L; Klain M; Pulcrano M; Angellotti G; Pasano F; Salvatore M; Lombardi G; Biondi B
    Minerva Endocrinol; 2004 Dec; 29(4):161-74. PubMed ID: 15765026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Thyroid activity in patients with thyroid neoplasms].
    Demidov VP; Agranat VZ; Ol'shanskiĭ VO; Babakulyeva D; Voronetskiĭ IB
    Vopr Onkol; 1983; 29(11):27-32. PubMed ID: 6649540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.